Dataset Information


Integrative MHC-I peptidome quantitation with isobaric tagging mass spectrometry

ABSTRACT: Despite the appreciation of CD8+ T cell anti-tumor immune responses towards improvement patient outcomes, the MHC-I peptides that facilitate the response are poorly described. Alternatively, whether cancer therapies alter the MHC-I peptide repertoire has not been fully assessed due to the lack of quantitative strategies. In this regard, anthracyclines and ionizing radiation both increase the infiltration of CD8+ T cells into tumors but whether they do so by altering the MHC-I peptidome repertoire is not known. To investigate this, we developed a platform for screening therapy-induced MHC-I peptides by quantitative, multiplexed measurement of MHC-I peptides with tandem mass tags (TMT). We show that both ionizing radiation and the anthracycline doxorubicin induce MHC-I peptides that are largely derived from mitotic progression and cell cycle proteins. Our approach enables further strategies to understand how small molecules and other therapies alter MHC-I peptide presentation that may be harnessed for CD8+ T cell-based immunotherapies.

INSTRUMENT(S): Orbitrap Fusion

ORGANISM(S): Homo sapiens  

TISSUE(S): Cell Suspension Culture

DISEASE(S): Colon Cancer

SUBMITTER: Patrick Murphy  

LAB HEAD: Shashi Gujar

PROVIDER: PXD011464 | Pride | 2019-03-05


Dataset's files

Action DRS
286535_m12743Swissprot_all.mzid.gz Mzid
286536_m12744Swissprot_all.mzid.gz Mzid
286537_m12745Swissprot_all.mzid.gz Mzid
286538_m12746Swissprot_all.mzid.gz Mzid
286539_m12747Swissprot_all.mzid.gz Mzid
Items per page:
1 - 5 of 33
altmetric image


Multiplexed Relative Quantitation with Isobaric Tagging Mass Spectrometry Reveals Class I Major Histocompatibility Complex Ligand Dynamics in Response to Doxorubicin.

Murphy J Patrick JP   Yu Qijia Q   Konda Prathyusha P   Paulo Joao A JA   Jedrychowski Mark P MP   Kowalewski Daniel J DJ   Schuster Heiko H   Kim Youra Y   Clements Derek D   Jain Aditya A   Stevanovic Stefan S   Gygi Steven P SP   Mancias Joseph D JD   Gujar Shashi S  

Analytical chemistry 20190222 8

MHC-I peptides are intracellular-cleaved peptides, usually 8-11 amino acids in length, which are presented on the cell surface and facilitate CD8<sup>+</sup> T cell responses. Despite the appreciation of CD8<sup>+</sup> T-cell antitumor immune responses toward improvement in patient outcomes, the MHC-I peptide ligands that facilitate the response are poorly described. Along these same lines, although many therapies have been recognized for their ability to reinvigorate antitumor CD8<sup>+</sup>  ...[more]

Similar Datasets

2019-03-05 | PXD011444 | Pride
2019-03-13 | PXD010382 | Pride
2019-11-27 | PXD015207 | Pride
2021-03-12 | PXD023454 | Pride
1000-01-01 | S-EPMC3411949 | BioStudies
2016-01-01 | S-EPMC4896622 | BioStudies
2010-01-01 | S-EPMC2865159 | BioStudies
1000-01-01 | S-EPMC5354300 | BioStudies
2013-01-01 | S-EPMC3575485 | BioStudies
2016-01-01 | S-EPMC4756651 | BioStudies